Evaluation and Treatment of Erectile Dysfunction in Men With Diabetes Mellitus

作者: Jayant Dey , Mark Devin Shepherd

DOI: 10.4065/77.3.276

关键词:

摘要: Diabetic men have a more than 3-fold increased prevalence of erectile dysfunction (ED) compared with nondiabetic men. Erectile function is primarily vascular phenomenon, triggered by neurologic controls and facilitated appropriate hormonal psychological components. Recent advances in the understanding physiology penile vasculature its role male sexual performance influenced clinical approach to ED. The pathophysiological alterations leading impotence diabetic include vasculogenic, neurogenic, etiologies. A work-up, including thorough history physical examination, an important aspect ED management. Biochemical evaluations rule out secondary causes like hypogonadism thyroid abnormalities are suggested. Oral medications acting through phosphodiesterase inhibition revolutionized treatment Because high success rate treating various etiologies, these agents choice for most patients. Safety efficacy vacuum-constriction devices, intraurethral suppositories, intracavernosal injections, other therapies discussed. algorithm evaluation management provided use primary care setting.

参考文章(36)
Irwin Goldstein, Tom F. Lue, Harin Padma-Nathan, Raymond C. Rosen, William D. Steers, Pierre A. Wicker, Oral sildenafil in the treatment of erectile dysfunction. Sildenafil Study Group. The New England Journal of Medicine. ,vol. 338, pp. 1397- 1404 ,(1998) , 10.1056/NEJM199805143382001
Michael Wyllie, Roger Kirby, Culley C. Carson, Irwin Goldstein, Textbook of Erectile Dysfunction ,(1999)
D. E. Price, G. Cooksey, D. Jehu, S. Bentley, J. R. Hearnshaw, D. E. Osborn, The management of impotence in diabetic men by vacuum tumescence therapy. Diabetic Medicine. ,vol. 8, pp. 964- 967 ,(1991) , 10.1111/J.1464-5491.1991.TB01538.X
Melvin D. Cheitlin, Adolph M. Hutter, Ralph G. Brindis, Peter Ganz, Sanjay Kaul, Richard O. Russell, Randall M. Zusman, James S. Forrester, Pamela S. Douglas, David P. Faxon, John D. Fisher, Raymond J. Gibbons, Jonathan L. Halperin, Adolph M. Hutter, Judith S. Hochman, Sanjiv Kaul, William S. Weintraub, William L. Winters, Michael J. Wolk, Use of sildenafil (Viagra) in patients with cardiovascular disease Journal of the American College of Cardiology. ,vol. 33, pp. 273- 282 ,(1999) , 10.1016/S0735-1097(98)00656-1
Thomas M. Mills, Vernon T. Wiedmeier, Vivienne S. Stopper, Androgen maintenance of erectile function in the rat penis. Biology of Reproduction. ,vol. 46, pp. 342- 348 ,(1992) , 10.1095/BIOLREPROD46.3.342
A. Burnett, C. Lowenstein, D. Bredt, T. Chang, S. Snyder, Nitric oxide: a physiologic mediator of penile erection Science. ,vol. 257, pp. 401- 403 ,(1992) , 10.1126/SCIENCE.1378650
John Bancroft, F. C. W. Wu, Changes in erectile responsiveness during androgen replacement therapy. Archives of Sexual Behavior. ,vol. 12, pp. 59- 66 ,(1983) , 10.1007/BF01542116
D Vernet, L Cai, H Garban, M L Babbitt, F T Murray, J Rajfer, N F Gonzalez-Cadavid, Reduction of penile nitric oxide synthase in diabetic BB/WORdp (type I) and BBZ/WORdp (type II) rats with erectile dysfunction. Endocrinology. ,vol. 136, pp. 5709- 5717 ,(1995) , 10.1210/ENDO.136.12.7588327